-
Rated 5.00 out of 5
Add to Cart $65
R3TA is an experimental triple-agonist (GLP-1, GIP, and glucagon) designed for obesity and type 2 diabetes, showing strong effects on weight loss and blood sugar control in early trials.
– 10mg vial
– ≥99% purity
– Lyophilized powder
– For research use only
Add to Cart $65
R3TA is an experimental triple-agonist (GLP-1, GIP, and glucagon) designed for obesity and type 2 diabetes, showing strong effects on weight loss and blood sugar control in early trials.
– 10mg vial
– ≥99% purity
– Lyophilized powder
– For research use only
-
Rated 5.00 out of 5
Add to Cart $85
R3TA is an experimental triple-agonist (GLP-1, GIP, and glucagon) designed for obesity and type 2 diabetes, showing strong effects on weight loss and blood sugar control in early trials
– 20mg vial
– ≥99% purity
– Lyophilized powder
– For research use only
Add to Cart $85
R3TA is an experimental triple-agonist (GLP-1, GIP, and glucagon) designed for obesity and type 2 diabetes, showing strong effects on weight loss and blood sugar control in early trials
– 20mg vial
– ≥99% purity
– Lyophilized powder
– For research use only
-
Add to Cart $100
R3TA is an experimental triple-agonist (GLP-1, GIP, and glucagon) designed for obesity and type 2 diabetes, showing strong effects on weight loss and blood sugar control in early trials
– 30mg vial
– ≥99% purity
– Lyophilized powder
– For research use only
Add to Cart $100
R3TA is an experimental triple-agonist (GLP-1, GIP, and glucagon) designed for obesity and type 2 diabetes, showing strong effects on weight loss and blood sugar control in early trials
– 30mg vial
– ≥99% purity
– Lyophilized powder
– For research use only
